U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT06887517) titled 'Chinese Rheumatism Biobank(CRB)' on March 13.
Brief Summary: Early prediction of major organ damage in SLE needs to dynamically track the evolution of SLE patients before and after the onset of major organ damage, and analyze the microscopic molecular evolution patterns synchronized with the macroscopic pathophysiological changes.
Study Start Date: Feb. 10
Study Type: OBSERVATIONAL
Condition:
Lupus Erythematosus, Systemic
Intervention:
DRUG: Antimalarial with or without oral glucocorticosteroid
Intervention one: Antimalarial and Oral Glucocorticosteroid, Prednisone or equivalent dose of glucocorticoid tapering: 30mg per day(...